Understanding Protein Clumps in ALS and Frontotemporal Dementia

Unraveling the Aggregation of TDP43 Fragments Associated with ALS and FTD: Insights into Protein Quality Control Mechanisms and Cellular Vulnerability

NIH-funded research Texas Woman's University · NIH-11221623

This research explores how certain protein fragments clump together in brain cells, which is a key feature of diseases like ALS and frontotemporal dementia.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionTexas Woman's University NIH-funded
Lab location1 site (Denton, United States)
Project IDNIH-11221623 on NIH RePORTER

What this research studies

Our cells have ways to manage proteins and prevent them from clumping, but sometimes these systems don't work correctly, leading to diseases like ALS and frontotemporal dementia. This project looks closely at specific protein fragments, called TDP43 fragments, that are known to form harmful clumps in the brain. We want to understand how these fragments are created and how the cell's natural cleanup systems try to deal with them. By learning more about these processes, we hope to discover why some cells are more vulnerable to these protein clumps than others.

Who could benefit from this research

Good fit: This foundational laboratory research is relevant to patients living with or at risk for amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer's disease-related dementias (ADRD).

Not a fit: Patients will not receive direct clinical benefit from this basic science research, as it focuses on understanding disease mechanisms rather than immediate treatment.

Why it matters

Potential benefit: If successful, this work could lead to a deeper understanding of how ALS, frontotemporal dementia, and related dementias develop, potentially paving the way for new treatments.

How similar studies have performed: Our lab has previously studied similar disease-linked protein fragments, identifying distinct cellular pathways that help protect cells from aggregation.

Where this research is happening

Denton, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.